Skip to main content

Table 2 Demographic and clinical features of patients with NAFLD and controls.

From: Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study

 

Italian controls

Italian adult NAFLD

number

346

202

Sex F

74 (21)

41 (20)

Age years

47.7 ± 12

47.4 ± 11

BMI Kg/m2

25.1 ± 2.6*

27.4 ± 3.8*

Total cholesterol mg/dl

194 ± 34*

211 ± 43*

HDL cholesterol mg/dl

56.2 ± 13*

45.1 ± 12*

Triglycerides mg/dl

89 ± 43*

158 ± 91*

Fasting insulin IU/ml

13.4 ± 7*

16.8 ± 11*

Glucose mg/dl

88.5 ± 10*

98 ± 24*

HOMA-IR

2.9 ± 1.6*

4.1 ± 3.3*

ALT UI/ml

23 ± 9*

65 ± 46*

GGT UI/ml

23 ± 16*

87 ± 96*

Fibrosis stage F0/F1/F2/F3/F4

-

104/61/23/8/6

(52/30/11/4/3)

  1. * p < 0.0001 between Italian patients and controls, ():% values